Quick Summary — MEOH scores higher on quality with 8.2/10 vs HUN's 6.3/10. HUN trades at $14.99 while MEOH trades at $62.00. Both analyzed daily using SEC EDGAR data across 13 institutional models.
MEOH scores higher with a 8.2/10 quality rating vs HUN's 6.3/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.
At $14.99, HUN trades +36.2% above its Bayesian DCF fair value of $9.56, while MEOH at $62.00 trades +80.0% below its estimate of $111.57. MEOH shows a wider gap between price and intrinsic value.
HUN earns a Quality of Company score of 6.3/10 compared to MEOH's 8.2/10. This moderate difference suggests one company has an edge in fundamental quality, though both may offer investment merit depending on valuation. The QOC score synthesizes 32 signals spanning profitability margins, revenue growth, free cash flow, capital allocation, and leverage.
HUN carries a SAFE value trap risk (3/100) while MEOH shows SAFE risk (18/100). Both companies show manageable value trap risk, suggesting their current valuations are not artificially depressed by fundamental deterioration.
Both HUN and MEOH operate in Chemicals, which has 18 stocks tracked by CirclFi. Same-industry comparisons provide the most direct insight into relative valuation since both companies face similar regulatory environments, market dynamics, and competitive pressures. Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN), and ensemble methods (CUCE).
11 hidden models compare HUN vs MEOH differently — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more. Some may disagree with the 2 you see above.
Bloomberg Terminal: ~$2,000/mo · FactSet: ~$1,000/mo · CirclFi: $0.90/day
See All 13 Models — $0.90/dayWe don’t predict prices. We show you what 13 independent mathematical frameworks say a stock is worth — and let you decide.